Measuring Intrahepatic Vascular Changes Using Contrast-Enhanced Ultrasonography to Predict the Prognosis of Alcoholic Hepatitis Combined with Cirrhosis: A Prospective Pilot Study

Gut Liver. 2018 Sep 15;12(5):555-561. doi: 10.5009/gnl17342.

Abstract

Background/aims: Acute hepatic dysfunction combined with alcoholic hepatitis (AH) in alcoholic cirrhosis is related to hepatic hypo-perfusion secondary to intrahepatic necroinflammation, neoangiogenesis, and shunt. The hepatic vein arrival time (HVAT) assessed by microbubble contrast-enhanced ultrasonography (CEUS) is closely correlated with the severity of intrahepatic changes. We investigated the usefulness of HVAT to predict short-term mortality of AH in cirrhosis.

Methods: Thirty-nine patients with alcoholic cirrhosis (27 males) and AH were prospectively enrolled. HVAT study was performed within 3 days after admission using ultrasonic contrast (SonoVue®). The primary outcome was 12-week mortality.

Results: Twelve-week mortality developed in nine patients. HVAT was significantly different between the mortality and survival groups (9.3±2.0 seconds vs 12.6±3.5 seconds, p=0.002). The odds ratio of a shortened HVAT for 12-week mortality was 1.481 (95% confidence interval, 1.050-2.090; p=0.025). The area under the receiver operating characteristic curve of HVAT for 12-week mortality was 0.787 (p=0.010). The combination of MDF and HVAT ≥11.0 seconds resulted in an 87.5% survival rate even if the MDF score ≥32; however, HVAT <11.0 seconds was related with mortality despite a MDF score<32.

Conclusions: HVAT using microbubble CEUS could be a useful additional index to predict short-term mortality in patients with AH and cirrhosis.

Keywords: Hepatic veins; Hepatitis, alcoholic; Liver cirrhosis, alcoholic; Ultrasonography, contrast-enhanced.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Area Under Curve
  • Contrast Media
  • Female
  • Hepatic Veins / diagnostic imaging*
  • Hepatitis, Alcoholic / diagnostic imaging*
  • Hepatitis, Alcoholic / mortality
  • Humans
  • Liver Cirrhosis, Alcoholic / diagnostic imaging*
  • Liver Cirrhosis, Alcoholic / mortality
  • Male
  • Middle Aged
  • Phospholipids
  • Pilot Projects
  • Prognosis
  • Prospective Studies
  • ROC Curve
  • Sulfur Hexafluoride
  • Time Factors
  • Ultrasonography / methods*

Substances

  • Contrast Media
  • Phospholipids
  • contrast agent BR1
  • Sulfur Hexafluoride